Hyunseok Kang

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Venues

Head & neck

Journal for immunotherapy of cancer

Journal of clinical medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

University of California San Francisco

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California San Francisco Aug 07 2018

United States

Associate Professor of Clinical Medicine :: Medicine

Johns Hopkins University Jul 01 2015 - Jun 30 2018

United States

Assistant Professor :: Oncology

Johns Hopkins University Jul 01 2013 - Jun 30 2015

United States

Instructor :: Oncology

Publications

Devan Diwanji, Emmanuel Carrodeguas, Youngho Seo, Hyunseok Kang, Myat Han Soe, Janet M Chiang, Li Zhang, Chienying Liu, Spencer C Behr, Robert Richard Flavell
Comparative Uptake Patterns of Radioactive Iodine and [18F]-Fluorodeoxyglucose (FDG) in Metastatic Differentiated Thyroid Cancers. Journal of clinical medicine 13 (13) (2024)
Devan Diwanji, Emmanuel Carrodeguas, Youngho Seo, Hyunseok Kang, Myat Han Soe, Janet M Chiang, Li Zhang, Chienying Liu, Spencer C Behr, Robert Richard Flavell
Comparative Uptake Patterns of Radioactive Iodine and [18F]-Fluorodeoxyglucose (FDG) in Metastatic Differentiated Thyroid Cancers. Journal of clinical medicine 13 (13) (2024)
Rex H Lee, Angeline Truong, Xin Wu, Hyunseok Kang, Alain P Algazi, Ivan H El-Sayed, Jonathan R George, Chase M Heaton, William R Ryan, Patrick K Ha, Katherine C Wai
The neutrophil-to-lymphocyte ratio in salivary gland cancers treated with pembrolizumab. Head & neck (2023)
Glenn J Hanna, Myung-Ju Ahn, Jameel Muzaffar, Bhumsuk Keam, Daniel W Bowles, Deborah J Wong, Alan L Ho, Sung-Bae Kim, Francis P Worden, Tak Yun, Xianzhang Meng, Jan M Van Tornout, Maureen G Conlan, Hyunseok Kang
A Phase 2 Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Arushi Gulati, Karolina A Plonowska, Erika M Stephens, Sagar Kansara, Aaron L Zebolsky, Edgar Ochoa, Mary Jue Xu, Patrick K Ha, Chase M Heaton, Sue S Yom, Jason W Chan, Alain Patrick Algazi, Hyunseok Kang, William R Ryan
A prospective evaluation of neck and shoulder function following treatments of early-stage human papillomavirus-associated oropharynx cancer. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2023)
Audrey Humphries, Connie J Zhou, Madeleine Welsh, Melinda Lem, Hyunseok Kang, Alain P Algazi
Carboplatin and paclitaxel after anti-PD-1 or anti-PD-L1 antibody therapy in recurrent and/or metastatic squamous cell carcinoma of head and neck. Head & neck (2023)
Rex H Lee, Katherine C Wai, Jason W Chan, Patrick K Ha, Hyunseok Kang
Approaches to the Management of Metastatic Adenoid Cystic Carcinoma. Cancers 14 (22) (2022)
Robert I Haddad, Tanguy Y Seiwert, Laura Q M Chow, Shilpa Gupta, Jared Weiss, Iris Gluck, Joseph P Eder, Barbara Burtness, Makoto Tahara, Bhumsuk Keam, Hyunseok Kang, Kei Muro, Andrew Albright, Robin Mogg, Mark Ayers, Lingkang Huang, Jared Lunceford, Razvan Cristescu, Jonathan Cheng, Ranee Mehra
Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma. Journal for immunotherapy of cancer 10 (2) (2022)
Jong Chul Park, Arya Ashok, Chienying Liu, Hyunseok Kang
Real-World Experience of NTRK Fusion-Positive Thyroid Cancer. JCO precision oncology 6 (2022)
Alan L Ho, Nathan R Foster, Alex J Zoroufy, Jordan D Campbell, Francis Worden, Katharine Price, Douglas R Adkins, Daniel W Bowles, Hyunseok Kang, Barbara A Burtness, Eric J Sherman, Roscoe Morton, Luc G T Morris, Zaineb Nadeem, Nora Katabi, Pamela N Munster, Gary K Schwartz
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Rex H Lee, Hyunseok Kang, Sue S Yom, Agata Smogorzewska, Daniel E Johnson, Jennifer R Grandis
Treatment of Fanconi Anemia-Associated Head and Neck Cancer: Opportunities to Improve Outcomes. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Joseph O Humtsoe, Hyun-Su Kim, Brandon Leonard, Shizhang Ling, Bhumsuk Keam, Luigi Marchionni, Bahman Afsari, Michael Considine, Alexander V Favorov, Elana J Fertig, Hyunseok Kang, Patrick K Ha
Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma. Cancer research 81 (4) (2021)
Zhibin Cui, Hyunseok Kang, Jennifer R Grandis, Daniel E Johnson
CYLD Alterations in the Tumorigenesis and Progression of Human Papillomavirus-Associated Head and Neck Cancers. Molecular cancer research : MCR 19 (1) (2020)
Lori J Wirth, Eric Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen Lorch, Francis Worden, Marcia Brose, Jyoti Patel, Sophie Leboulleux, Yann Godbert, Fabrice Barlesi, John C Morris, Taofeek K Owonikoko, Daniel S W Tan, Oliver Gautschi, Jared Weiss, Christelle de la Fouchardière, Mark E Burkard, Janessa Laskin, Matthew H Taylor, Matthias Kroiss, Jacques Medioni, Jonathan W Goldman, Todd M Bauer, Benjamin Levy, Viola W Zhu, Nehal Lakhani, Victor Moreno, Kevin Ebata, Michele Nguyen, Dana Heirich, Edward Y Zhu, Xin Huang, Luxi Yang, Jennifer Kherani, S Michael Rothenberg, Alexander Drilon, Vivek Subbiah, Manisha H Shah, Maria E Cabanillas
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers. The New England journal of medicine 383 (9) (2020)
Jong Chul Park, Christine G Gourin, Ana P Kiess, Ranee Mehra, Arlene A Forastiere, Hyunseok Kang
Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States. Head & neck 40 (12) (2018)
Theodoros Karantanos, Lisa Rooper, Youme Kang, Cheng Ting Lin, Pawla Wenga, Sarah Sagorsky, Josh Lauring, Hyunseok Kang
Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1-Deficient Carcinoma. The oncologist 24 (2) (2018)
Won Jin Ho, Lisa Rooper, Sarah Sagorsky, Hyunseok Kang
A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report. Journal for immunotherapy of cancer 6 (1) (2018)
Jong Chul Park, Ting Martin Ma, Lisa Rooper, Todd Hembrough, Robert D Foss, Nicole C Schmitt, Rishi Sawhney, Aaron Flanders, Hyunseok Kang
Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor-2 high expressing salivary duct carcinomas. Head & neck 40 (12) (2018)
Won Jin Ho, Mark Yarchoan, Alex Hopkins, Ranee Mehra, Stuart Grossman, Hyunseok Kang
Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas. Journal for immunotherapy of cancer 6 (1) (2018)
Hyunseok Kang, Dean Pettinga, Adrian D Schubert, Paul W Ladenson, Douglas W Ball, Jon H Chung, Alexa B Schrock, Russell Madison, Garrett M Frampton, Phil J Stephens, Jeffrey S Ross, Vincent A Miller, Siraj M Ali
Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy. The oncologist 24 (6) (2018)

Hyunseok Kang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hyunseok Kang